U.S. Patents of National Jewish Health

Links to the U.S. Patent and Trademark Office Database

PAT. NO.

Title

8,685,740

Methods to Determine Susceptibility to Treatment with Leukotriene Modifiers

8,673,300

Therapeutic Compositions and Methods for the Prevention of Autoimmune Diseases

8,673,565

Methods and Compositions for Risk Prediction, Diagnosis, Prognosis and Treatment of Pulmonary Disorders

8,652,475

Inhibition of Factor B, the Alternative Complement Pathway and Methods Related Thereto

8,629,107

Genes and Proteins Associated With Angiogenesis and Uses Thereof

8,609,432

Method and Kit for Detection of Autoimmune Chronic Urticaria

8,512,414

Airway Anchor Suture to Prevent Airway Stent Migration

8,465,923

Markers for Diagnosis of Pulmonary Inflammation and Methods Related Thereto

8,367,643

Surfactant Lipids, Compositions Thereof and Uses Thereof

8,178,098

Method to Inhibit Airway Hyperresponsiveness Using Aerosolized T Cell Receptor Antibodies

8,101,361

Markers for Diagnosis of Pulmonary Inflammation and Methods Related Thereto

8,158,107

Genes and Proteins Associated With Angiogenesis and Uses Thereof

8,101,361

Markers for Diagnosis of Pulmonary Inflammation and Methods Related Thereto

8,058,396

Cystatin C as an Antagonist of TGF-β and Methods Related Thereto

7,999,082

Anti-factor B Antibodies

7,994,115

Three Dimensional Structures of TALL-1 and its Cognate Receptors Related Thereto and Uses and Molecules

7,825,224

Product and Method for Treatment of Conditions Associated with Receptor-desensitization

7,825,089

Three-dimensional Structures of TALL-1

7,772,011

Method and Kit for Detection of Autoimmune Chronic Urticaria

7,754,705

Cationic Steroid Antimicrobial Compositions and Methods of Use

7,741,300

Methods of Using Nucleic Acid Vector-lipid Complexes

7,749,958

Cystatin C as an Antagonist of TGF-.beta. and Methods Related Thereto

7,582,300

Modulation of Gamma Delta T Cells to Regulate Airway Hyperresponsiveness

7,534,438

Product and Process for Liquefaction of Mucus or Sputum

7,498,047

Methods for Treatment of Thiol-containing Compound Deficient Conditions

7,468,048

Joint Aspirate Facilitating Device

7,374,934

Cell Populations and Methods of Production Thereof

7,282,477

Cystatin C as an Antagonist of TGF-.beta. and Methods Related Thereto

7,189,707

Substituted Porphyrins

7,169,570

Method to Identify Regulators of Cellular Activation Using Bcl10

7,160,681

Method for Regulating Cell Growth and Assays Related Thereto

7,090,865

Composition and Method for Treating Autoimmune Hemolytic Anemia

6,951,733

Method for Testing Drug Susceptibility of Mycobacterium Tuberculosis

6,916,799

Substituted Porphyrins

6,875,749

Methods for Facilitating Vascular Growth

6,737,398

Modulation of Gamma Delta T Cells to Regulate Airway Hyperresponsiveness

6,693,086

Systemic Immune Activation Method Using Nucleic Acid-lipid Complexes

6,579,694

Agar Medium for the Growth of Mycobacterium Tuberculosis

6,576,433

Method for Identification of Cell Growth or Differentiation Factors

6,555,318

Method for Identification of Cell Growth or Differentiation Factors

6,544,975

Substituted Porphyrins

6,503,509

Method for Receptor Desensitization

6,497,840

Ultraviolet Germicidal System

6,479,477

Substituted Porphyrins

6,475,987

Tall-1 Receptor Homologues

6,399,607

Aminomethylene Amide Analogs of Pyrazinamide with Intracellular Antimycobacterial Activity Against Pyrazinamide-resistant Mycobacteria Combined with a Rifamycin

6,333,170

Method and Product for Regulating Cell Responsiveness to External Signals

6,306,612

Methods of Facilitating Vascular Growth

6,264,888

Ultraviolet Germicidal Apparatus and Method

6,231,894

Treatments Based on Discovery that Nitric Oxide Synthase is a Paraquat Diaphorase

6,187,584

Products and Processes for Regulation of Gene Recombination

6,156,503

Diagnosing Asthma Patients Predisposed to Adverse.beta.-agonist Reactions

6,110,739

Method to Produce Novel Embryonic Cell Populations

6,074,861

MEKK Proteins

6,040,152

Method and Assay for Regulation of T Cell Proliferation

5,985,261

Use of Thioredoxin-like Molecules for Induction of MnSOD to Treat Oxidative Damage

5,981,265

Methods for Regulating MEKK Protein Activity

5,959,074

Products and Processes for Regulation of Gene Recombination

5,935,568

Gene Therapy for Effector Cell Regulation

5,914,268

Embryonic Cell Populations and Methods to Isolate Such Populations

5,874,301

Embryonic Cell Populations and Methods to Isolate Such Populations

5,820,866

Product and Process for T Cell Regulation

5,405,941

MEKK Protein Capable of Phosphorylating MEK


 

For more information, contact Emmanuel Hilaire at HilaireE@njhealth.org

Product and method for treatment of conditions associated with receptor-desensitization

Faculty by Research

The discoveries made in the laboratories at National Jewish Health have a profound impact on the understanding and treatment of human disease.

Browse our Faculty by Area of Research.

Events

MAY
01
New York AIR Society
5/1/2014 7:00:00 PM
MAY
17
Cocktails with Class
5/17/2014 6:00:00 PM